EGFR and prostate carcinoma: EGFR signaling pathways promote proliferation, survival, invasiveness and metastasis of prostate cancer cells 10-12 and EGFR expression correlates with grading, recurrence, poorer metastasis-free survival and therapeutic resistance of prostate cancer 13-16.